Zhitong Finance App learned that Sansheng Pharmaceutical (01530), Shisi Pharmaceutical Group (02005), Fengyi Technology (01304), Yuanda Pharmaceutical (00512), Daoxiang Holdings (00573), and Gushengtang (02273) made the latest shareholders' rights disclosure on September 8, 2026.

Stock name	Name of organization	nature	Pre-change shareholding	Shareholding after the change	Shareholding ratio
Sansheng Pharmaceutical (01530)	Lou Jing	Yoshigura	534 million shares	534 million shares	21.13% (latest) 21.11% (previous)
Shisi Pharmaceutical Group (02005)	China Pharmaceutical Company Limited	Yoshigura	9.12 billion shares	9.13 billion shares	30.95% (latest) 30.91% (previous)
Fengyi Technology (01304)	Moselle Limited	Yoshigura	10.1803 million shares	9.2091 million shares	9.84% (latest) 10.88% (previous)
Fengyi Technology (01304)	Shanghai Huaxin Venture Capital Partnership (Limited Partnership)	Yoshigura	10.1803 million shares	9.2091 million shares	9.84% (latest) 10.88% (previous)
Yuanda Pharmaceutical (00512)	Zhou Chao	Yoshigura	511,000 shares	53.25 million shares	0.02% (Latest) 0.01% (Previous)
Daoxiang Holdings (00573)	Chung Wai Ping	Yoshigura	4.60 billion shares	4.60 billion shares	45.35% (latest) 45.33% (previous)
Shisi Pharmaceutical Group (02005)	Qu Jiguang	Yoshigura	1,263 million shares	1,264 million shares	42.84% (latest) 42.80% (previous)
Koseido (02273)	Tu Zhiliang	Yoshigura	82.0834 million shares	82.0934 million shares	35.03% (latest) 35.02% (previous)

Note: Changes in the number of shares held may be caused by stock offerings, joint stock splits, etc. Please be careful to compare the actual situation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.